Latest drug development News

Fellowship to boost Australia’s drug discovery capabilities
WHO and MPP announce agreement with NIH for Covid health technologies
Leading cancer researcher joins SAiGENCI
Microba announces new research partnership and senior appointment
New cancer drug formulations to be tested in Wollongong labs
Promising nose spray could prevent and treat Covid
US FDA grants new orphan designation to Noxopharm’s Veyonda
$185 million investment to fast-track treatments for rare and ‘untreatable’ cancers
Backing life-saving local cancer drug development
Boost to funding for R&D trials to find treatments for MND
Molecular Horizons receives funding from Michael Tynan Challenge
Mutant mice shed no tears
University of Toronto Entrepreneurship Week 2022: 10 startups to watch
Repurposing FDA-approved drugs may help combat Covid
Nirsevimab EMA regulatory submission accepted under accelerated assessment for RSV protection in all infants
Ensuring artificial intelligence technologies for health benefit older people
Put that on CV: impact of research
New trial underway of Pharmaxis’ first-in-class LOX inhibitor
Exopharm announces new agreement with Astellas Institute for Regenerative Medicine
University of Toronto drug discovery startup BenchSci raises $63 million in funding: Globe and Mail, Betakit
University of Toronto drug discovery startup BenchSci raises $63 million in funding: Globe & Mail, Betakit
Pharmaxis welcomes government research grants for new study collaborations
First patient dosed in phase I/IIa trial of lung cancer immunotherapy vaccine
Protective gene variant against Covid identified
AstraZeneca and Scorpion Therapeutics enter agreement to discover, develop and commercialise novel cancer treatments against
$25.6 million investment to turbocharge Australian health projects
Homogeneous hydrogenolysis with molecular palladium
Making more effective and efficient RNA therapeutics
Researchers design microfluidic device to understand how air pollution affects lungs
Enzyme research unlocks gateway for new medicines
UWA and Neuro Vigor announce drug development collaboration
UNSW academic to help establish $96m RNA pilot manufacturing facility
Research-industry partnership to advance biologic therapies
Record year for University of Manchester’s Innovation Factory
Funding boost expands MND research in our region
Indian regulator approves study of Dimerix’s DMX-200 in Covid
New research shows drug repurposing is no ‘quick-fix’ in race to treat Covid
SUDA Pharmaceuticals announces ‘firm commitments’ on capital raise
Bright ideas among $31M Australian Government funding boost
CannaPacific and CSIRO trial novel encapsulation technologies for medicinal cannabinoids
Noxopharm completes $23m share placement
Novartis signs US$50 million commercial deal with Australian biotech firm
Weill Cornell entrepreneurship symposium touts innovation
Necrotising enterocolitis treatment closer
Baricitinib treatment linked to reduced mortality in COVID-19 patients
Sugar-coated viral proteins hijack and hitch a ride out of cells
New Hope for Alzheimer’s Disease
New understanding of how proteins operate